MLB Notes: Have Ohtani and Acuña locked up MVP?
Published Thu, 11 Jul 2024 01:39:57 GMT
Suicide bomber detonates a device in the Turkish capital. A second assailant is killed in a shootout
Published Thu, 11 Jul 2024 01:39:57 GMT
Evacuated Illinois residents return home after ammonia leak from truck crash that killed 5 people
Published Thu, 11 Jul 2024 01:39:57 GMT
Pakistani Taliban attack a police post in eastern Punjab province, killing 1 officer
Published Thu, 11 Jul 2024 01:39:57 GMT
Yemen’s state-run airline suspends the only route out of Sanaa over Houthi restrictions on its funds
Published Thu, 11 Jul 2024 01:39:57 GMT
Overdoses from smoking toxic drugs outpace B.C. prevention sites
Published Thu, 11 Jul 2024 01:39:57 GMT
Save the Children advocate says aid cut hinders Canada’s leadership in youth rights
Published Thu, 11 Jul 2024 01:39:57 GMT
Daily horoscope for October 1, 2023
Published Thu, 11 Jul 2024 01:39:57 GMT
Iran protesters mark anniversary of “Bloody Friday” in south-eastern Sistan and Baluchestan province
Published Thu, 11 Jul 2024 01:39:57 GMT
DC artist’s paintings were stolen, but she refuses to call police
Published Thu, 11 Jul 2024 01:39:57 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says